ValiRx Income Statement

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	0.03	0.05	0.01	-	-
Revenue Growth (YoY)	-36.97%	418.49%	-	-	-
Cost of Revenue	0.04	-	0	-	-
Gross Profit	-0.01	0.05	0.01	-	-
Selling, General & Admin	1.59	1.98	1.89	1.5	1.22
Research & Development	0.23	0.25	0.38	0.55	0.3
Other Operating Expenses	-	-0.03	-	-	-0.03
Operating Expenses	1.82	2.19	2.31	2.59	1.68
Operating Income	-1.82	-2.14	-2.3	-2.59	-1.68
Interest Expense	-0	-0	-0	-0.01	-0
Interest & Investment Income	0.01	0.01	-	-	-
EBT Excluding Unusual Items	-1.82	-2.13	-2.3	-2.6	-1.68
Impairment of Goodwill	-0.6	-	-	-	-
Pretax Income	-2.42	-2.13	-2.3	-2.6	-1.68
Income Tax Expense	-0.13	-0.13	-0.18	-0.19	-0.13
Earnings From Continuing Operations	-2.29	-2	-2.13	-2.41	-1.55
Net Income to Company	-2.29	-2	-2.13	-2.41	-1.55
Minority Interest in Earnings	0.06	0.09	0.09	0.04	0.03
Net Income	-2.23	-1.92	-2.04	-2.37	-1.52
Net Income to Common	-2.23	-1.92	-2.04	-2.37	-1.52
Shares Outstanding (Basic)	414	132	102	77	65
Shares Outstanding (Diluted)	414	132	102	77	65
Shares Change (YoY)	213.81%	29.74%	31.39%	18.92%	71.53%
EPS (Basic)	-0.01	-0.01	-0.02	-0.03	-0.02
EPS (Diluted)	-0.01	-0.01	-0.02	-0.03	-0.02
Free Cash Flow	-1.52	-1.62	-2.06	-1.71	-1.26
Free Cash Flow Per Share	-0.00	-0.01	-0.02	-0.02	-0.02
Gross Margin	-19.92%	100.00%	85.00%	-	-
Operating Margin	-5809.21%	-4302.70%	-23943.12%	-	-
Profit Margin	-7115.13%	-3848.71%	-21226.05%	-	-
Free Cash Flow Margin	-4856.94%	-3260.70%	-21495.13%	-	-
EBITDA	-1.59	-1.87	-2.05	-2.39	-1.46
D&A For EBITDA	0.24	0.27	0.25	0.2	0.22
EBIT	-1.82	-2.14	-2.3	-2.59	-1.68